Abeona Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +12.4% | -14.5% | -5.8% | +258.2% | -100.0% | – | -70.0% | -52.9% | +147.5% | -100.0% | – | |
| – | +172,945.5% | -44.0% | +59.4% | +127.8% | +25.5% | -37.9% | +28.5% | -98.8% | +256.7% | +81.1% | -47.3% | |
| – | +12.4% | -1,039.0% | – | – | – | – | -70.0% | -67.9% | +96.6% | -253.4% | – | |
| – | +1,315.9% | +126.0% | +59.4% | +127.8% | +38.9% | -43.9% | +28.5% | -25.2% | +7.3% | +10.5% | -22.0% | |
| – | +285.8% | -7.2% | -17.7% | +83.7% | +3.0% | +14.8% | -9.0% | -20.3% | +10.1% | +57.1% | +117.9% | |
| – | +382.9% | +26.5% | +15.8% | +113.3% | -53.4% | +220.5% | +1.5% | -44.1% | -5.5% | +25.0% | +52.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.0% | +0.0% | +33.3% | +37.5% | +3,536.4% | +928.8% | -11.2% | -79.9% | -43.2% | +906.7% | -11.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +591.8% | -50.0% | -73.9% | +186.9% | -73.4% | +928.8% | -10.8% | -314.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.